Clinical Outcomes of Surgically Managed Spontaneous Tumors in 114 Client-owned Dogs.
- Author:
Ji Won CHOI
1
;
Hun Young YOON
;
Soon Wuk JEONG
Author Information
- Publication Type:Original Article
- Keywords: Tumor; Surgical Outcome; Dog
- MeSH: Adenocarcinoma; Adenoma; Animals; Biopsy; Diagnosis; Dogs*; Female; Humans; Male; Mammary Glands, Human; Medical Records; Mouth; Neoplasm Metastasis; Palliative Care; Recurrence; Retrospective Studies; Sarcoma; Skin
- From:Immune Network 2016;16(2):116-125
- CountryRepublic of Korea
- Language:English
- Abstract: Medical records of 139 tumors from 114 dogs that underwent surgery from May 2010 through March 2015 were retrospectively reviewed. Among 114 dogs, females (64.9%) were significantly more common than males (35.1%) (p<0.05). Dogs aged 6 to 10 years were more presented than non-tumor patients, however, there was no significant difference. The mean age (±SD) was 10.3±3.0 years. Although we found no significant difference of breed predisposition, the most common breed was Maltese (19.3%), followed by Shih-Tzu (14.0%), and Yorkshire terrier (13.2%). Proportional morbidity ratios (PMRs) of mammary gland, oral cavity, and skin tumors were high in Poodles, Yorkshire terriers, and Golden retrievers, respectively. Mammary gland (36.0%) was the most common site, followed by skin and soft tissues (12.2%), oral cavity (10.8%), and digestive organs (8.6%), but there was no significant difference. The objectives of surgery were curative surgery (86.2%), biopsy (4.9%), and palliative surgery (6.5%). In this study, 123 of 139 tumors had histopathological diagnoses. Adenocarcinoma was the most common type (n=24), followed by adenoma (n=17), soft tissue sarcoma (n=13), benign mixed tumor (n=5), and others (n=64). Recurrence or suspected metastasis was identified in 26 dogs. Median survival times of malignant mammary gland tumors, skin and subcutaneous tumors, and splenic tumors were 1,563.0±1,201.7, 469, and 128 days, respectively.
